INFORMACIÓN BÁSICA SOBRE COOKIES

Una cookie o galleta informática es un pequeño archivo de información que se guarda en su navegador cada vez que visita nuestra página web.
La utilidad de las cookies es guardar el historial de su actividad en nuestra página web, de manera que, cuando la visite nuevamente, ésta pueda identificarle y configurar el contenido de la misma en base a sus hábitos de navegación, identidad y preferencias.
Las cookies pueden ser aceptadas, rechazadas, bloqueadas y borradas, según desee. Ello podrá hacerlo mediante las opciones disponibles en la presente ventana o a través de la configuración de su navegador, según el caso.
En caso de que rechace las cookies no podremos asegurarle el correcto funcionamiento de las distintas funcionalidades de nuestra página web.
Más información en el apartado POLÍTICA DE COOKIES de nuestra página web.

ACEPTAR RECHAZAR

LIST OF CLINICAL TRIALS

Search for clinical trials open in our centers by cancer type.

PLEASE MAKE A SELECTION TO
BROWSE RESULTS

OPEN TRIAL CLOSED TRIAL

BREAST CANCER

POSITIVE [OPEN TRIAL]

Study to evaluate the effect of pregnancy and the safety of interupting endocrine treatment in young women with breast cancer responding to endocrine treatment who wish to become pregnant. Protocol: IBCSG 48‐14 / BIG 8‐13

+ INFO

LUNG AND PLEURAL CANCER

PTEROSTILBENE [OPEN TRIAL]

Observational study in patients treated with EGFR/IT inhibitors and pterostilbene.

+ INFO

SOLID TUMORS

PUMA [OPEN TRIAL]

An open-label, phase 2 study of Neratinib in patients with solid tumors with somatic human epidermal growth factor receptor (EGFR, HER2, HER3) mutations or EGFR gene amplification.

+ INFO

LUNG AND PLEURAL CANCER

SELINA [OPEN TRIAL]

Analysis of soluble mediators, cytokines, and circulating angiogenic factors (CAFs) as potential predictors / prognostic factors in antiangiogenic treatment after failure of first-line chemotherapy in advanced non-squamous lung carcinoma.

+ INFO

BREAST CANCER

SHERBOC [OPEN TRIAL]

A Double-blind, Placebo-controlled, Phase 2 trial of Seribantumab Plus Fulvestrant in Postmenopausal Women with Hormone Receptor-positive, Heregulin Positive (HRG+), HER2 Negative Metastatic Breast Cancer Whose Disease Progressed After Prior Systemic Therapy. Protocol: MM-121-02-02-10.

+ INFO

SOLID TUMORS

SYM015 [OPEN TRIAL]

An open-label, multicenter phase 1a/2a trial investigating the safety, tolerability and antitumor activity of multiple doses of Sym015, a monoclonal antibody mixture targeting MET, in patients with advanced solid tumor malignancies.

+ INFO

LUNG AND PLEURAL CANCER

VISION [OPEN TRIAL]

Single group, phase II trial to investigate tepotinib in pulmonary adenocarcinoma in stage IIIB / IV with alterations by omission of exon 14 of MET (METex14) after failure to at least one previous active treatment, including one with platinum doublet. Protocol: MS200095-002

+ INFO

LUNG AND PLEURAL CANCER

X396-CLI-301 [OPEN TRIAL]

Phase III randomized study comparing X-396 vs crizotinib in patients with non small cell lung cancer (NSCLC) positive for the anaplastic lymphoma kinase (ALK).

+ INFO